Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
CPL-409116 by Celon Pharma for Plaque Psoriasis (Psoriasis Vulgaris): Likelihood of Approval
CPL-409116 is under clinical development by Celon Pharma and currently in Phase I for Plaque Psoriasis (Psoriasis Vulgaris). According to...
Data Insights
CPL-409116 by Celon Pharma for Rheumatoid Arthritis: Likelihood of Approval
CPL-409116 is under clinical development by Celon Pharma and currently in Phase II for Rheumatoid Arthritis. According to GlobalData, Phase...